Cardiovascular risk among giant cell arteritis patients
GCA significantly increases risks of vascular complications, highlighting the importance of cardiovascular risk management and inflammation control strategies.
Authors
- Maxime Beydon (ORCID: https://orcid.org/0000-0003-4924-093X)
- Florence Tubach (ORCID: https://orcid.org/0000-0002-7802-944X)
- Børge Grønne Nordestgaard (ORCID: https://orcid.org/0000-0002-1954-7220)
- A Guedon
- Ariel Cohen (ORCID: https://orcid.org/0000-0002-3329-2412)
- Olivier Fain
- Etienne Ghrenassia
- Raphaèle Seror
- Azeddine Dellal
- Arsène Mekinian
- Fabrice Carrat
Institutions
- University of Copenhagen (DK)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Université Paris-Saclay (FR)
- Frederiksberg Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Antoine (FR)
- Paris Cardiovascular Research Center (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Institut du Thorax (FR)
- Groupe Hospitalier Intercommunal Le Raincy Montfermeil (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1093/eurjpc/zwag034
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 36.44